As CACHD1 plays a crucial role in regulating the cell cycle and autophagy process, it has been identified as a potential early biomarker of liver preneoplastic and neoplastic lesions associated with NASH (Table 1 and Table 2). Here, CACHD1 is linked to metabolic dysfunction-associated steatohepatitis.